Int. J. Mol. Sci. 2011, 12(10), 6980-7003; doi:10.3390/ijms12106980
Review

Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies

1,2email, 2email and 1,* email
Received: 28 September 2011; in revised form: 9 October 2011 / Accepted: 11 October 2011 / Published: 19 October 2011
(This article belongs to the Special Issue Studies of Motor Molecules)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by progressive muscle wasting and weakness with no effective cure. Emerging evidence supports the notion that the abnormal conformations of ALS-linked proteins play a central role in triggering the motor neuron degeneration. In particular, mutant types of superoxide dismutase 1 (SOD1) and TAR DNA binding protein 43kDa (TDP-43) are key molecules involved in the pathogenesis of familial and sporadic ALS, respectively. The commonalities of the two proteins include a propensity to aggregate and acquire detrimental conformations through oligomerization, fragmentation, or post-translational modification that may drive abnormal subcellular localizations. Although SOD1 is a major cytosolic protein, mutated SOD1 has been localized to mitochondria, endoplasmic reticulum, and even the extracellular space. The nuclear exclusion of TDP-43 is a pathological hallmark for ALS, although the pathogenic priority remains elusive. Nevertheless, these abnormal behaviors based on the protein misfolding are believed to induce diverse intracellular and extracellular events that may be tightly linked to non-cell-autonomous motor neuron death. The generation of mutant- or misfolded protein-specific antibodies would help to uncover the distribution and propagation of the ALS-linked proteins, and to design a therapeutic strategy to clear such species. Herein we review the literature regarding the mislocalization of ALS-linked proteins, especially mutant SOD1 and TDP-43 species, and discuss the rationale of molecular targeting strategies including immunotherapy.
Keywords: seeding; subcellular localization; SOD1; TDP-43; non-cell-autonomous motor neuron death; antibody
PDF Full-text Download PDF Full-Text [576 KB, Updated Version, uploaded 19 June 2014 04:03 CEST]
The original version is still available [355 KB, uploaded 19 June 2014 04:03 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Ido, A.; Fukuyama, H.; Urushitani, M. Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies. Int. J. Mol. Sci. 2011, 12, 6980-7003.

AMA Style

Ido A, Fukuyama H, Urushitani M. Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies. International Journal of Molecular Sciences. 2011; 12(10):6980-7003.

Chicago/Turabian Style

Ido, Akemi; Fukuyama, Hidenao; Urushitani, Makoto. 2011. "Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies." Int. J. Mol. Sci. 12, no. 10: 6980-7003.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert